Observational studyBMC gastroenterology2026
Real-world efficacy and safety of sofosbuvir/velpatasvir/voxilaprevir in treatment-naive and treatment-experienced chronic hepatitis c patients: a single-center study.
Alper Tahmaz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.